CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 40 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 1,000 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -66.7% | 1,000 | 0.0% | 0.00% | – |
| Q3 2018 | $6,000 | +20.0% | 1,000 | -6.4% | 0.00% | – |
| Q4 2017 | $5,000 | +25.0% | 1,068 | +53.2% | 0.00% | – |
| Q3 2017 | $4,000 | – | 697 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|